RossStuartBerkowitzMD
Obstetrics & Gynecology • Boston, MAGynecologic Oncology
Gyn Oncology at Brigham and Women's Hospital
Dr. Berkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis Street
Brigham And Womens Hospital Division Of Gynecologic Onc
Boston, MA 02115Phone+1 617-732-8843- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1980- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 1975 - 1978
- Brigham and Women's HospitalResidency, Surgery, 1973 - 1975
Boston University School of MedicineClass of 1973
Certifications & Licensure
MA State Medical License 1978 - 2025
ME State Medical License 2022 - 2025
VT State Medical License 2022 - 2024
RI State Medical License 2021 - 2024
CT State Medical License 2022 - 2024
NH State Medical License 2022 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Start of enrollment: 2008 Aug 01
- Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia.Luz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, Gustavo Jankilevich, Silvina Otero, Carlos Raúl Villegas Mejía, Rafael Cortés-Charry, Kevin M Elias, ...> ;Revista Brasileira De Ginecologia e Obstetricia. 2022 Aug 1
- Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.Marina Georgiou, Panagiota Ntavelou, William Stokes, Rajat Roy, Geoffrey J Maher, Tsvetana Stoilova, Josephine A M Y Choo, Callum P Rakhit, Miguel Martins, Paul Ajuh, ...> ;Oncogene. 2022 Jun 1
- 2 citationsThe role of natural killer cells in the immune homeostasis of the maternal fetal interfaceKornél Lakatos, Kevin M Elias, Ross S Berkowitz, Kathleen Hasselblatt, György Végh, Vilmos Fülöp> ;Orvosi Hetilap. 2022 May 8
- Join now to see all
Journal Articles
- Distinct microRNA Profiles for Complete Hydatidiform Moles at Risk for Malignant ProgressionNeil S Horowitz, Donald P Goldstein, Bradley J Quade, Ross S Berkowitz, Kevin M Elias, American Journal of Obstetrics and Gynecology
- Update on the Diagnosis and Management of Gestational Trophoblastic DiseaseRoss S Berkowitz, John R Lurain, International Journal of Gynecology & Obstetrics
- Comparison of Benign Peritoneal Fluid- and Ovarian Cancer Ascites-Derived Extracellular Vesicle RNA BiomarkersRoss S Berkowitz, Michael G Muto, BioMed Central
Press Mentions
Your Daily Phil: Moishe House Opens 30 New Locations + Connecting Shmita to FundraisingOctober 4th, 2021
Professional Memberships
- Fellow
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
